DOCSLIB.ORG

Critical Role of IL-12 in Dendritic Cell-Induced Differentiation of Naive B Lymphocytes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Critical Role of IL-12 in Dendritic Cell-Induced Differentiation of Naive B Lymphocytes Critical Role of IL-12 in Dendritic Cell-Induced Differentiation of Naive B Lymphocytes This information is current as Bertrand Dubois, Catherine Massacrier, Béatrice Vanbervliet, of September 29, 2021. Jérome Fayette, Francine Brière, Jacques Banchereau and Christophe Caux J Immunol 1998; 161:2223-2231; ; http://www.jimmunol.org/content/161/5/2223 Downloaded from References This article cites 64 articles, 39 of which you can access for free at: http://www.jimmunol.org/content/161/5/2223.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 29, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 1998 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Critical Role of IL-12 in Dendritic Cell-Induced Differentiation of Naive B Lymphocytes1,2 Bertrand Dubois, Catherine Massacrier, Be´atrice Vanbervliet, Je´rome Fayette, Francine Brie`re, Jacques Banchereau,3 and Christophe Caux4 Dendritic cells (DC) are potent APCs initiating immune responses. In a previous report, we demonstrated that DC directly enhance both proliferation and differentiation of CD40-activated naive and memory B cells. The present study deciphers the molecular mechanisms involved in DC-dependent regulation of B cell responses. Herein, we have identified IL-12 as the mandatory molecule secreted by CD40-activated DC that promote the differentiation of naive B cells into plasma cells secreting high levels of IgM. In fact, IL-12 synergizes with soluble IL-6R a-chain (sgp80), produced by DC, to drive naive B cell differentiation. IL-12 is critical for the differentiation of naive B cells into IgM plasma cells, whereas IL-6R signaling mainly promotes Ig secretion by already differentiated B cells. The differentiation of naive B cells in cocultures of B cells, T cells, and DC is IL-12 dependent, definitely Downloaded from demonstrating that the role of DC in humoral responses is not confined to the activation of T cells and further extending the physiologic relevance of DC/B cell interaction. Finally, this study also identifies differential requirements for DC-dependent naive and memory B cell differentiation, the latter being IL-12 independent. Altogether these results indicate that, in addition to prime T cells toward Th1 development, DC, through the production of IL-12, may also directly signal naive B cell during the initiation of the immune response. The Journal of Immunology, 1998, 161: 2223–2231. http://www.jimmunol.org/ endritic cells (DC)5 are bone marrow-derived leukocytes critical importance as illustrated in the hyper IgM syndrome (15) with potent immunostimulatory properties (1). In the pe- or mice deficient for CD40 or CD40L (16, 17). D riphery, DC such as epidermal Langerhans cells, capture Although studies have underlined the specific role of DC in invading Ag/pathogen and migrate via the lymph stream into humoral responses (4–7), the extent to which DC can directly reg- draining lymph nodes. In the paracortical areas, these DC, called ulate B cell activation requires further analysis. Recent progress in interdigitating cells present processed peptides to naive T cells and the propagation of DC in vitro from precursors (18) and in their initiate the immune response. This T cell activation is followed by purification from blood (19) or tonsils (20, 21) has enabled such cognate interaction between Ag-specific T cells and B cells (2), studies. Recently, several findings have suggested that DC may by guest on September 29, 2021 leading to primary Ab production. The essential role of DC in directly regulate B cell activation during the course of the humoral humoral response has been documented in vitro (3) and in vivo response (22–25). In particular, we showed that DC, generated by (4–7) and is thought to be the consequence of the requirement for culturing cord blood CD341 progenitors for 12 days in presence of DC for naive T cell priming. Once activated, T cells express CD40 GM-CSF 1 TNF-a (26, 27), strongly enhance growth and differ- ligand (CD40L), which in return signal DC to up-regulate costimu- entiation of CD40-activated B cells (22). In the present study, latory molecules (CD54, CD80, CD86) and to secrete cytokines aimed at characterizing the molecules involved in the effects of DC (IL-1, IL-6, IL-8, IL-12, TNF-a) (8, 9). In parallel, CD40L ex- on B cells, we demonstrate that 1) DC-derived IL-12 is mandatory pressing T cells together with cytokines promotes B cell survival in inducing naive, but not memory, B cell differentiation, and that (10), proliferation (11), as well as B cell differentiation and isotype 2) DC strongly enhance Ig production by naive and memory B switching (12, 13). Thus, among the signals involved in DC/T cells by potentiating the IL-6-dependent pathway of B cell differ- cell/B cell cooperation, CD40/CD40L interactions (14) appear of entiation. These findings demonstrate that DC-derived IL-12 can directly signal B cells and thus influence the initiation and subse- quent development of the humoral response. Laboratory for Immunological Research, Schering Plough, Dardilly, France Received for publication January 14, 1998. Accepted for publication May 4, 1998. The costs of publication of this article were defrayed in part by the payment of page Materials and Methods charges. This article must therefore be hereby marked advertisement in accordance Hemopoietic factors, cytokines, Abs, and cell lines with 18 U.S.C. Section 1734 solely to indicate this fact. 3 6 1 rhGM-CSF (specific activity: 2 10 U/mg, Schering-Plough Research Preliminary results were presented at the 4th International Symposium on Dendritic Institute, Kenilworth, NJ) was used at a saturating concentration of 100 Cells in Fundamental and Clinical Immunology, held in Venice, Italy, October 1996. ng/ml (200 U/ml). rhTNF-a (specific activity: 2 3 107 U/mg, Genzyme, 2 B.D. was supported by Foundation Marcel Me´rieux, Lyon, France, and J.F. by Ecole Boston, MA) was used at an optimal concentration of 2.5 ng/ml (50 U/ml). Normale Supe´rieure de Lyon, France. Recombinant human stem cell factor (specific activity 4 3 105 U/mg, R&D 3 Current address: Baylor Institute for Immunology Research, 3500 Gaston Avenue, Systems, Abington, U.K.) was used at an optimal concentration of 25 ng/ P.O. Box 710699, Dallas, Texas 75246. ml. rhIL-2 (specific activity: 3 3 106 U/mg, Amgen, Thousand Oaks, CA) 3 7 3 5 4 Address correspondence and reprints requests to Dr. Christophe Caux, Laboratory was used at 20 U/ml. rhIL-12 (1 10 U/mg) and rhsgp80 (1 10 U/mg) for Immunological Research, Schering-Plough, 27 chemin des Peupliers, BP 11, were purchased from R&D Systems and used at 1 ng/ml and 100 ng/ml, 69571 Dardilly, France. E-mail address: [email protected] respectively. rhIL-6, purified from Escherichia coli by ion-exchange chro- . 5 Abbreviations used in this paper: DC, dendritic cell; CD40L, CD40 ligand; GM- matography ( 95% pure), was obtained from DNAX (Palo Alto, CA) and CSF, granulocyte-macrophage CSF; h, human; SAC, Staphylococcus aureus strain used at 10 ng/ml. Formalinized particles of Staphylococcus aureus strain Cowan I; PE, phycoerythrin; SEA, staphylococcal enterotoxin A; SEB, staphylococ- Cowan I (SAC) were purchased as Pansorbin from Calbiochem-Behring cal enterotoxin B; SAg, superantigen; GCDC, germinal center DC. (La Jolla, CA) and were used at a final concentration of 0.01%. Copyright © 1998 by The American Association of Immunologists 0022-1767/98/$02.00 2224 IL-12-DEPENDENT NAIVE B CELL DIFFERENTIATION The following blocking Abs were used at 10 mg/ml: mouse anti-IL-2 and showed the absence of detectable contaminating T cells throughout the mAb (R&D Systems) and mouse anti-gp80 mAb (Diaclone, Besanc¸on, culture. France, and R&D Systems), goat anti-IL-12 and goat anti-IFN-g Abs For certain experiments, naive B cells (104) were cultured in presence (R&D Systems), mouse anti-IL-12 mAb (IgG1, clone C8.6), kindly pro- of irradiated (4000 rad) allogeneic CD41 T cells (105) and increasing num- vided by A. O’Garra, DNAX, Palo Alto, CA), rat anti-hIL-10R mAb (clone bers of irradiated DC (3,000 rad) with or without superantigens (SEA 1 3F9) and anti-hIL-10 mAb (clone 12G8, kindly provided by K. Moore, SEB, 10 ng/ml each). In certain culture conditions, DC were incubated for DNAX), mouse IgG1, goat IgG, and rabbit IgG isotype control Abs (R&D 1 h with SEA 1 SEB, washed 4 times, irradiated (4000 rad), and used to Systems), mouse anti-CD40 (mAb89) and anti-CD40L (LL48) mAbs (pro- stimulate cocultures of T and B cells. duced in our laboratory). In other experiments, B cells and DC were cultured in separate com- The murine fibroblastic cell line stably transfected with human CD40L partments using transwells (Costar, Wilmington, MA). DC (105) cultured (CD40L L cells) was produced in the laboratory as described earlier (28). in the presence or the absence of CD40 triggering (2.5 3 104 irradiated Mouse fibroblastic L cells transfected with the human CD32/FcgRII (29) CD40L L cells or CD32 L cells used as control) in the lower compartment were used as control L cells.
Load more

Recommended publications
  • B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells
    cells Review B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells Carlo G. Bonasia 1 , Wayel H. Abdulahad 1,2 , Abraham Rutgers 1, Peter Heeringa 2 and Nicolaas A. Bos 1,* 1 Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, 9713 Groningen, GZ, The Netherlands; [email protected] (C.G.B.); [email protected] (W.H.A.); [email protected] (A.R.) 2 Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 Groningen, GZ, The Netherlands; [email protected] * Correspondence: [email protected] Abstract: Autoreactive B cells are key drivers of pathogenic processes in autoimmune diseases by the production of autoantibodies, secretion of cytokines, and presentation of autoantigens to T cells. However, the mechanisms that underlie the development of autoreactive B cells are not well understood. Here, we review recent studies leveraging novel techniques to identify and characterize (auto)antigen-specific B cells. The insights gained from such studies pertaining to the mechanisms involved in the escape of tolerance checkpoints and the activation of autoreactive B cells are discussed. Citation: Bonasia, C.G.; Abdulahad, W.H.; Rutgers, A.; Heeringa, P.; Bos, In addition, we briefly highlight potential therapeutic strategies to target and eliminate autoreactive N.A. B Cell Activation and Escape of B cells in autoimmune diseases. Tolerance Checkpoints: Recent Insights from Studying Autoreactive Keywords: autoimmune diseases; B cells; autoreactive B cells; tolerance B Cells. Cells 2021, 10, 1190. https:// doi.org/10.3390/cells10051190 Academic Editor: Juan Pablo de 1.
    [Show full text]
  • Overview of B-Cell Maturation, Activation, Differentiation
    Overview of B-Cell Maturation, Activation, Differentiation B-Cell Development Begins in the Bone Marrow and Is Completed in the Periphery Antigen-Independent (Maturation) 1) Pro-B stages B-cell markers 2) Pre B-stages H- an L- chain loci rearrangements surrogate light chain 3) Naïve B-cell functional BCR . B cells are generated in the bone marrow. Takes 1-2 weeks to develop from hematopoietic stem (HSC) cells to mature B cells. Sequence of expression of cell surface receptor and adhesion molecules which allows for differentiation of B cells, proliferation at various stages, and movement within the bone marrow microenvironment. HSC passes through progressively more delimited progenitor-cell stages until it reaches the pro-B cell stage. Pre-B cell is irreversibly committed to the B-cell lineage and the recombination of the immunoglobulin genes expressed on the cell surface Immature B cell (transitional B cell) leaves the bone marrow to complete its maturation in the spleen through further differentiation. Immune system must create a repertoire of receptors capable of recognizing a large array of antigens while at the Source: Internet same time eliminating self-reactive B cells. B-Cell Activation and Differentiation • Exposure to antigen or various polyclonal mitogens activates resting B cells and stimulates their proliferation. • Activated B cells lose expression of sIgD and CD21 and acquire expression of activation antigens. Growth factor receptors, structures involved in cell-cell interaction, molecules that play a role in the localization and binding of activated B cells Two major types: T cell dependent (TD) T cell independent (TI) B-Cell Activation by Thymus-Independent and Dependent Antigens Source: Kuby T cell dependent: Involves protein antigens and CD4+ helper T cells.
    [Show full text]
  • The TNF-Family Cytokine TL1A Drives IL-13-Dependent Small Intestinal Inflammation
    ARTICLES nature publishing group See ARTICLE page 186 The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation F M e y l a n 1 , 6 , Y - J S o n g 1 , 6 , I F u s s 2 , S V i l l a r r e a l 1 , E K a h l e 1 , I - J M a l m 1 , K A c h a r y a 1 , H L R a m o s 3 , L L o 4 , M M M e n t i n k - K a n e 5 , T A W y n n 5 , T - S M i g o n e 4 , W S t r o b e r 2 a n d R M S i e g e l 1 The tumor necrosis factor (TNF)-family cytokine TL1A (TNFSF15) costimulates T cells through its receptor DR3 (TNFRSF25) and is required for autoimmune pathology driven by diverse T-cell subsets. TL1A has been linked to human inflammatory bowel disease (IBD), but its pathogenic role is not known. We generated transgenic mice that constitutively express TL1A in T cells or dendritic cells. These mice spontaneously develop IL-13-dependent inflammatory small bowel pathology that strikingly resembles the intestinal response to nematode infections. These changes were dependent on the presence of a polyclonal T-cell receptor (TCR) repertoire, suggesting that they are driven by components in the intestinal flora. Forkhead box P3 (FoxP3)-positive regulatory T cells (Tregs) were present in increased numbers despite the fact that TL1A suppresses the generation of inducible Tregs.
    [Show full text]
  • B-Cell Reconstitution Recapitulates B-Cell Lymphopoiesis Following Haploidentical BM Transplantation and Post-Transplant CY
    Bone Marrow Transplantation (2015) 50, 317–319 © 2015 Macmillan Publishers Limited All rights reserved 0268-3369/15 www.nature.com/bmt LETTER TO THE EDITOR B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY Bone Marrow Transplantation (2015) 50, 317–319; doi:10.1038/ From week 9, the proportion of transitional B cells progressively bmt.2014.266; published online 24 November 2014 decreased (not shown), whereas that of mature B cells increased (Figure 1d). To further evaluate the differentiation of mature cells, we included markers of naivety (IgM and IgD) and memory (IgG) in The treatment of many hematological diseases benefits from our polychromatic panel. At week 9, when a sufficient proportion myeloablative or non-myeloablative conditioning regimens of cells were available for the analysis, B cells were mostly naive followed by SCT or BMT. HLA-matched donors are preferred but and remained so for 26 weeks after haploBMT (Figure 1d). Despite not always available. Instead, haploidentical donors can be rapidly low, the proportion of memory B cells reached levels similar to identified. Unmanipulated haploidentical BMT (haploBMT) with that of marrow donors (Supplementary Figure 1D). non-myeloablative conditioning and post-transplant Cy has been To further investigate the steps of B-cell maturation, we developed to provide a universal source of BM donors.1 Cy, analyzed CD5, a regulator of B-cell activation, and CD21, a which depletes proliferating/allogeneic cells, prevents GVHD.1 component of the B-cell coreceptor complex, on transitional B Importantly, the infection-related mortality was remarkably low, cells. These surface markers characterize different stages of 5,6 5,6 suggesting effective immune reconstitution.1,2 However, a transitional B-cell development.
    [Show full text]
  • Human B Cell Isolation Product Selection Diagram
    Human B Cell Isolation Product Selection Explore the infographic below to find the correct human B cell isolation product for your application. 1. Your Starting Sample Whole Peripheral Blood/Buffy Coat PBMCs/Leukapheresis Pack 2. Cell Separation Platform Immunodensity Cell Separation Immunomagnetic Cell Separation Immunomagnetic Cell Separation 3. Product Line RosetteSep™ EasySep™ EasySep™ Sequential Selection Negative Selection Negative Selection Positive Selection Negative Selection Positive Selection 4. Selection Method (Positive + Negative) iRosetteSep™ HLA iEasySep™ Direct HLA i, iiEasySep™ HLA iEasySep™ HLA B Cell viEasySep™ Human CD19 EasySep™ Human IgG+ B Cell Enrichment Cocktail B Cell Isolation Kit Chimerism Whole Blood Enrichment Kit Positive Selection Kit II Memory B Cell Isolation (15064HLA)1, 2, 3 (89684) / EasySep™ Direct B Cell Positive Selection (19054HLA)1, 2 (17854)1, 2 Kit (17868)1 (optional), 2' HLA Crossmatch B Cell Kit (17886)1, 2 Isolation Kit (19684 - 1, 2 RosetteSep™ Human available in the US only) iiiEasySep™ Human B Cell viEasySep™ Release EasySep™ Human Memory 5. Cell Isolation Kits B Cell Enrichment Cocktail i, iiEasySep™ HLA Enrichment Kit Human CD19 Positive B Cell Isolation Kit 1, 2, 3 1, 2 1, 2 1 (optional), 2 Catalog #s shown in ( ) (15024) Chimerism Whole Blood (19054) Selection Kit (17754) (17864) EasySep™ Direct Human CD19 Positive Selection B-CLL Cell Isolation Kit Kit (17874)1, 2 1, 2, 3, 4 *RosetteSep™ Human (19664) iiiEasySep™ Human B Cell EasySep™ Human CD138 Multiple Myeloma Cell Isolation Kit
    [Show full text]
  • Lymphopenia-Induced Proliferation Lymphocytes During and After
    The Journal of Immunology Effects of Increasing IL-7 Availability on Lymphocytes during and after Lymphopenia-Induced Proliferation1 Nabil Bosco,* Fabien Agene`s,* and Rhodri Ceredig2† IL-7 is critically involved in regulating peripheral T cell homeostasis. To investigate the role of IL-7 on lymphopenia-induced proliferation of polyclonal lymphocytes, we have transferred CFSE-labeled cells into a novel T-lymphopenic, IL-7-transgenic mouse line. Results obtained indicate that T and B cells do not respond in the same way to IL-7-homeostatic signals. Overex- pression of IL-7 enhances proliferation of both CD4؉ and CD8؉ T cells but with distinctly temporal effects. Expansion of naturally arising CD4؉-regulatory T cells was like that of conventional CD4؉ T cells. IL-7 had no effect on B cell proliferation. By immunohistology, transferred T cells homed to T cell areas of spleen lymphoid follicles. Increasing IL-7 availability enhanced T cell recovery by promoting cell proliferation and reducing apoptosis during early stages of lymphopenia-induced proliferation. Taken together, these results provide new insights into the pleiotropic effects of IL-7 on lymphopenia-induced T cell proliferation. The Journal of Immunology, 2005, 175: 162–170. espite declining thymic output with age, the peripheral T either IL-7-deficient or wild-type mice treated with anti-IL-7 or cell pool of an adult animal remains remarkably stable anti-IL-7R␣ mAb show that perturbation of IL-7 signals prevents D (1, 2). How the T cell pool is maintained remains a cen- the expansion of transferred T cells (1, 10).
    [Show full text]
  • 1 the Immune System
    1 The immune system The immune response Innate immunity Adaptive immunity The immune system comprises two arms (rapid response) (slow response) functioning cooperatively to provide a Dendritic cell Mast cell comprehensive protective response: the B cell innate and the adaptive immune system. Macrophage γδ T cell T cell The innate immune system is primitive, does not require the presentation of an antigen, Natural and does not lead to immunological memory. killer cell Basophil Its effector cells are neutrophils, Complement protein macrophages, and mast cells, reacting Antibodies Natural Eosinophil killer T cell CD4+ CD8+ within minutes to hours with the help of T cell T cell complement activation and cytokines (CK). Granulocytes Neutrophil B-lymphocytes B-cell receptor The adaptive immune response is provided by the lymphocytes, which precisely recognise unique antigens (Ag) through cell-surface receptors. epitope Receptors are obtained in billions of variations through antigen cut and splicing of genes and subsequent negative T-lymphocytes selection: self-recognising lymphocytes are eradicated. T-cell receptor Immunological memory after an Ag encounter permits a faster and heightened state of response on a subsequent exposure. epitope MHC Lymphocytes develop in primary lymphoid tissue (bone marrow [BM], thymus) and circulate towards secondary Tonsils and adenoids Lymph lymphoid tissue (lymph nodes [LN], spleen, MALT). nodes Lymphatic vessels The Ag reach the LN carried by lymphocytes or by Thymus dendritic cells. Lymphocytes enter the LN from blood Lymph transiting through specialised endothelial cells. nodes The Ag is processed within the LN by lymphocytes, Spleen macrophages, and other immune cells in order to mount a specific immune response.
    [Show full text]
  • Module 3: Development of Immune Cells
    NPTEL – Biotechnology – Cellular and Molecular Immunology Module 3: Development of immune cells Lecture 15: Development of Lymphocytes (Part I) Pluripotent stem cells and fetal liver are considered as hematopoietic stem cells in the body which give rise to lineages of blood cells. Hematopoietic stem cells also differentiate into B cells, T cells, and antigen presenting cells following maturation. The maturation of B cells mostly occurs in the fetal liver before birth and in the bone marrow after birth. The T cells form in the liver before birth and complete maturation in thymus after birth. The most common form of T cells i.e αβ T cells develop in the bone marrow while less common form γδ T cells develop in neonatal liver. The differentiation of B and T lymphocytes from precursor stem cells largely depends on the signals induced by the surface receptors present over the hematopoietic stem cells which induce different transcriptional factors involved in its maturation. 15.1 Differentiation of B and T lymphocytes from progenitor cells 15.1.1 B cells differentiation Pluripotent hematopoietic stem cells differentiate into B cells under the influence of transcription factors E2A, EBF, and Pax5. These transcription factor works synergistically to induce the transcription of specific genes and their recombination responsible for the development of B lymphocytes. Pluripotent hematopoietic stem cells are differentiated into Pro-B cells which give rise to follicle B cells, marginal B cells, and B-1 B cells. 15.1.2 T cell differentiation Pluripotent hematopoietic stem cells first give rise to common lymphoid progenitor cells. The common lymphoid progenitor cells can either give rise to natural killer cells or Pro-T cells under the influence of different transcriptional factors.
    [Show full text]
  • CD8 Naive T Cell Counts Decrease Progressively in HIV-Infected Adults
    CD8 naive T cell counts decrease progressively in HIV-infected adults. M Roederer, … , L A Herzenberg, L A Herzenberg J Clin Invest. 1995;95(5):2061-2066. https://doi.org/10.1172/JCI117892. Research Article We show here that CD8 naive T cells are depleted during the asymptomatic stage of HIV infection. Although overall CD8 T cell numbers are increased during this stage, the naive CD8 T cells are progressively lost and fall in parallel with overall CD4 T cell counts. In addition, we show that naive CD4 T cells are preferentially lost as total CD4 cell counts fall. These findings, presented here for adults, and in the accompanying study for children, represent the first demonstration that HIV disease involves the loss of both CD4 T cells and CD8 T cells. Furthermore, they provide a new insight into the mechanisms underlying the immunodeficiency of HIV-infected individuals, since naive T cells are required for all new T cell-mediated immune responses. Studies presented here also show that the well-known increase in total CD8 counts in most HIV-infected individuals is primarily due to an expansion of memory cells. Thus, memory CD8 T cells comprise over 80% of the T cells in PBMC from individuals with < 200 CD4/microliter, whereas they comprise roughly 15% in uninfected individuals. Since the naive and memory subsets have very different functional activities, this altered naive/memory T cell representation has significant consequences for the interpretation of data from in vitro functional studies. Find the latest version: https://jci.me/117892/pdf CD8 Naive T Cell Counts Decrease Progressively in HIV-infected Adults Mario Roederer, J.
    [Show full text]
  • Immunology 101
    Immunology 101 Justin Kline, M.D. Assistant Professor of Medicine Section of Hematology/Oncology Committee on Immunology University of Chicago Medicine Disclosures • I served as a consultant on Advisory Boards for Merck and Seattle Genetics. • I will discuss non-FDA-approved therapies for cancer 2 Outline • Innate and adaptive immune systems – brief intro • How immune responses against cancer are generated • Cancer antigens in the era of cancer exome sequencing • Dendritic cells • T cells • Cancer immune evasion • Cancer immunotherapies – brief intro 3 The immune system • Evolved to provide protection against invasive pathogens • Consists of a variety of cells and proteins whose purpose is to generate immune responses against micro-organisms • The immune system is “educated” to attack foreign invaders, but at the same time, leave healthy, self-tissues unharmed • The immune system can sometimes recognize and kill cancer cells • 2 main branches • Innate immune system – Initial responders • Adaptive immune system – Tailored attack 4 The immune system – a division of labor Innate immune system • Initial recognition of non-self (i.e. infection, cancer) • Comprised of cells (granulocytes, monocytes, dendritic cells and NK cells) and proteins (complement) • Recognizes non-self via receptors that “see” microbial structures (cell wall components, DNA, RNA) • Pattern recognition receptors (PRRs) • Necessary for priming adaptive immune responses 5 The immune system – a division of labor Adaptive immune system • Provides nearly unlimited diversity of receptors to protect the host from infection • B cells and T cells • Have unique receptors generated during development • B cells produce antibodies which help fight infection • T cells patrol for infected or cancerous cells • Recognize “foreign” or abnormal proteins on the cell surface • 100,000,000 unique T cells are present in all of us • Retains “memory” against infections and in some cases, cancer.
    [Show full text]
  • Human Naive B Cells Cells by Cpg Oligodeoxynucleotide-Primed T+
    Presentation of Soluble Antigens to CD8+ T Cells by CpG Oligodeoxynucleotide-Primed Human Naive B Cells This information is current as Wei Jiang, Michael M. Lederman, Clifford V. Harding and of September 27, 2021. Scott F. Sieg J Immunol 2011; 186:2080-2086; Prepublished online 14 January 2011; doi: 10.4049/jimmunol.1001869 http://www.jimmunol.org/content/186/4/2080 Downloaded from References This article cites 36 articles, 21 of which you can access for free at: http://www.jimmunol.org/content/186/4/2080.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 27, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2011 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Presentation of Soluble Antigens to CD8+ T Cells by CpG Oligodeoxynucleotide-Primed Human Naive B Cells Wei Jiang,*,† Michael M. Lederman,*,† Clifford V. Harding,†,‡ and Scott F. Sieg*,† Naive B lymphocytes are generally thought to be poor APCs, and there is limited knowledge of their role in activation of CD8+ T cells.
    [Show full text]
  • Plasma Cells: Finding New Light at the End of B Cell Development Kathryn L
    © 2001 Nature Publishing Group http://immunol.nature.com REVIEW Plasma cells: finding new light at the end of B cell development Kathryn L. Calame Plasma cells are cellular factories devoted entire- Upon plasma cell differentiation, there is a marked increase in ly to the manufacture and export of a single prod- steady-state amounts of Ig heavy and light chain mRNA and, when 2 uct: soluble immunoglobulin (Ig). As the final required for IgM and IgA secretion, J chain mRNA . Whether the increase in Ig mRNA is due to increased transcription, increased mediators of a humoral response, plasma cells mRNA stability or, as seems likely, both mechanisms, remains con- play a critical role in adaptive immunity.Although troversial2. There is also an increase in secreted versus membrane intense effort has been devoted to studying the forms of heavy chain mRNA, as determined by differential use of poly(A) sites that may involve the availability of one component of regulation and requirements for early B cell the polyadenylation machinery, cleavage-stimulation factor Cst-643. development, little information has been avail- To accommodate translation and secretion of the abundant Ig able on plasma cells. However, more recent mRNAs, plasma cells have an increased cytoplasmic to nuclear ratio work—including studies on genetically altered and prominent amounts of rough endoplasmic reticulum and secreto- ry vacuoles. mice and data from microarray analyses—has Numerous B cell–specific surface proteins are down-regulated begun to identify the regulatory cascades that upon plasma cell differentiation, including major histocompatibility initiate and maintain the plasma cell phenotype. complex (MHC) class II, B220, CD19, CD21 and CD22.
    [Show full text]